Novo Financial Statements From 2010 to 2025

Novo Nordisk Balance Sheet		Trends
Current Value Last Year Historical Average  10 Year Trend Total Assets 489.1 B 465.8 B 166.5 B Slightly volatile Short and Long Term Debt Total 107.9 B 102.8 B 19.5 B Slightly volatile Total Current Liabilities 228.4 B 217.5 B 78.5 B Slightly volatile Total Stockholder Equity 150.7 B 143.5 B 64.7 B Slightly volatile Property Plant And Equipment Net 170.6 B 162.5 B 54.4 B Slightly volatile Retained Earnings 151.7 B 144.4 B 64.5 B Slightly volatile Cash 8.3 B 15.7 B 13.3 B Pretty Stable Non Current Assets Total 320.1 B 304.9 B 91.6 B Slightly volatile Cash And Short Term Investments 27.6 B 26.3 B 18.4 B Slightly volatile Net Receivables 91.8 B 87.4 B 36.1 B Slightly volatile Common Stock Shares Outstanding 3.7 B 4.5 B 3.9 B Slightly volatile Liabilities And Stockholders Equity 489.1 B 465.8 B 166.5 B Slightly volatile Non Current Liabilities Total 110 B 104.8 B 23.2 B Slightly volatile Inventory 42.9 B 40.8 B 18.5 B Slightly volatile Total Liabilities 338.4 B 322.3 B 101.7 B Slightly volatile Property Plant And Equipment Gross 225.6 B 214.9 B 68.1 B Slightly volatile Total Current Assets 168.9 B 160.9 B 74.9 B Slightly volatile Short Term Debt 13.8 B 13.1 B 3.9 B Slightly volatile Intangible Assets 95.6 B 91 B 23.3 B Slightly volatile Accounts Payable 30.3 B 28.8 B 10.1 B Slightly volatile Common Stock Total Equity 493.1 M 423 M 516.9 M Slightly volatile Common Stock 473.9 M 446 M 514.6 M Slightly volatile Other Liabilities 15.1 B 14.4 B 6.1 B Slightly volatile Property Plant Equipment 80.5 B 76.7 B 37.3 B Slightly volatile Current Deferred Revenue 129.9 B 123.7 B 46.6 B Slightly volatile Other Assets 16.2 B 15.4 B 6 B Slightly volatile Net Tangible Assets 37 B 36.9 B 29.1 B Slightly volatile Long Term Investments 1.6 B 2.7 B 1.3 B Slightly volatile Net Invested Capital 251.5 B 239.5 B 88.1 B Slightly volatile Capital Stock 372 M 446 M 471.7 M Slightly volatile
Novo Nordisk Income Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Depreciation And Amortization 9 B 8.5 B 3.5 B Slightly volatile Selling General Administrative 6.5 B 5.3 B 4 B Slightly volatile Total Revenue 304.9 B 290.4 B 134.9 B Slightly volatile Gross Profit 258.2 B 245.9 B 113.3 B Slightly volatile Other Operating Expenses 170.2 B 162.1 B 77.5 B Slightly volatile Operating Income 134.8 B 128.3 B 57.4 B Slightly volatile EBIT 135.3 B 128.8 B 58.3 B Slightly volatile EBITDA 144.2 B 137.4 B 61.8 B Slightly volatile Cost Of Revenue 46.7 B 44.5 B 21.6 B Slightly volatile Total Operating Expenses 123.4 B 117.5 B 55.9 B Slightly volatile Income Before Tax 133.6 B 127.2 B 56.3 B Slightly volatile Net Income 106 B 101 B 44.7 B Slightly volatile Income Tax Expense 27.5 B 26.2 B 11.5 B Slightly volatile Research Development 50.5 B 48.1 B 19.3 B Slightly volatile Net Income Applicable To Common Shares 67 B 63.9 B 33.5 B Slightly volatile Selling And Marketing Expenses 34.5 B 62.1 B 32.4 B Slightly volatile Net Income From Continuing Ops 106 B 101 B 39.7 B Slightly volatile Tax Provision 14.4 B 26.2 B 11.8 B Slightly volatile Interest Income 1.2 B 1.8 B 2.8 B Slightly volatile Reconciled Depreciation 20.1 B 19.1 B 6.4 B Slightly volatile
Novo Nordisk Cash Flow Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Free Cash Flow 73.1 B 69.7 B 38.3 B Slightly volatile Begin Period Cash Flow 8.6 B 14.4 B 12.8 B Pretty Stable Depreciation 9 B 8.5 B 4.8 B Slightly volatile Capital Expenditures 53.9 B 51.3 B 15.7 B Slightly volatile Total Cash From Operating Activities 127 B 121 B 54 B Slightly volatile Net Income 106 B 101 B 44.7 B Slightly volatile End Period Cash Flow 9.1 B 15.7 B 13.1 B Pretty Stable Dividends Paid 46.3 B 44.1 B 19.9 B Slightly volatile
Financial Ratios		Trends
Current Value Last Year Historical Average  10 Year Trend Price To Sales Ratio 10.05 9.5733 8.073 Slightly volatile Dividend Yield 0.0154 0.0159 0.0178 Pretty Stable PTB Ratio 20.34 19.3756 16.8858 Slightly volatile Days Sales Outstanding 65.31 110 81.9603 Slightly volatile Book Value Per Share 33.83 32.2158 13.6674 Slightly volatile Free Cash Flow Yield 0.0329 0.0251 0.0382 Slightly volatile Operating Cash Flow Per Share 28.52 27.16 11.4972 Slightly volatile Stock Based Compensation To Revenue 0.0043 0.0079 0.0051 Slightly volatile Capex To Depreciation 6.3 6.0046 2.7267 Slightly volatile PB Ratio 20.34 19.3756 16.8858 Slightly volatile EV To Sales 10.37 9.8734 8.0247 Slightly volatile Free Cash Flow Per Share 16.42 15.64 8.0872 Slightly volatile ROIC 0.22 0.3899 0.5103 Very volatile Inventory Turnover 1.69 1.0899 1.2716 Slightly volatile Net Income Per Share 23.81 22.6741 9.4809 Slightly volatile Days Of Inventory On Hand 215 335 292 Slightly volatile Payables Turnover 1.47 1.5434 2.9778 Slightly volatile Sales General And Administrative To Revenue 0.0173 0.0182 0.0339 Slightly volatile Research And Ddevelopement To Revenue 0.17 0.1655 0.1396 Very volatile Capex To Revenue 0.12 0.1767 0.0948 Slightly volatile Cash Per Share 6.2 5.9067 3.8469 Slightly volatile POCF Ratio 24.13 22.9823 20.9734 Slightly volatile Interest Coverage 74.34 78.2555 214 Very volatile Payout Ratio 0.26 0.4371 0.412 Pretty Stable Capex To Operating Cash Flow 0.53 0.4242 0.2812 Pretty Stable PFCF Ratio 41.91 39.9105 29.028 Slightly volatile Days Payables Outstanding 248 236 143 Slightly volatile Income Quality 1.44 1.1978 1.2528 Very volatile ROE 0.74 0.7038 0.6474 Slightly volatile EV To Operating Cash Flow 24.89 23.7026 20.8055 Slightly volatile PE Ratio 28.91 27.5293 25.134 Slightly volatile Return On Tangible Assets 0.15 0.2847 0.3112 Very volatile EV To Free Cash Flow 43.22 41.1613 28.6674 Slightly volatile Earnings Yield 0.0345 0.0363 0.0463 Slightly volatile Intangibles To Total Assets 0.25 0.2385 0.0954 Slightly volatile Current Ratio 0.7 0.7397 1.2836 Slightly volatile Tangible Book Value Per Share 4.76 7.2736 7.5624 Slightly volatile Receivables Turnover 5.42 3.3222 4.8493 Slightly volatile Graham Number 135 128 53.8722 Slightly volatile Shareholders Equity Per Share 33.83 32.2158 13.6674 Slightly volatile Debt To Equity 0.75 0.7164 0.1837 Slightly volatile Capex Per Share 12.1 11.52 3.41 Slightly volatile Revenue Per Share 68.46 65.202 28.4886 Slightly volatile Interest Debt Per Share 24.62 23.4462 4.548 Slightly volatile Debt To Assets 0.23 0.2207 0.0665 Slightly volatile Enterprise Value Over EBITDA 21.92 20.8716 18.0273 Slightly volatile Short Term Coverage Ratios 9.76 10.2733 57.2764 Pretty Stable Price Earnings Ratio 28.91 27.5293 25.134 Slightly volatile Operating Cycle 281 445 374 Slightly volatile Price Book Value Ratio 20.34 19.3756 16.8858 Slightly volatile Days Of Payables Outstanding 248 236 143 Slightly volatile Dividend Payout Ratio 0.26 0.4371 0.412 Pretty Stable Price To Operating Cash Flows Ratio 24.13 22.9823 20.9734 Slightly volatile Price To Free Cash Flows Ratio 41.91 39.9105 29.028 Slightly volatile Pretax Profit Margin 0.22 0.438 0.3811 Pretty Stable Ebt Per Ebit 1.86 0.9911 1.0859 Very volatile Operating Profit Margin 0.46 0.4419 0.3991 Slightly volatile Effective Tax Rate 0.3 0.206 0.2197 Pretty Stable Company Equity Multiplier 3.41 3.2463 2.2764 Slightly volatile Long Term Debt To Capitalization 0.39 0.3699 0.1521 Slightly volatile Total Debt To Capitalization 0.44 0.4174 0.1281 Slightly volatile Return On Capital Employed 0.29 0.5169 0.6665 Very volatile Debt Equity Ratio 0.75 0.7164 0.1837 Slightly volatile Ebit Per Revenue 0.46 0.4419 0.3991 Slightly volatile Quick Ratio 0.52 0.5519 0.9589 Slightly volatile Dividend Paid And Capex Coverage Ratio 1.31 1.2674 1.666 Slightly volatile Net Income Per E B T 0.58 0.794 0.7728 Very volatile Cash Ratio 0.0684 0.072 0.3589 Slightly volatile Cash Conversion Cycle 205 208 246 Pretty Stable Operating Cash Flow Sales Ratio 0.22 0.4166 0.359 Slightly volatile Days Of Inventory Outstanding 215 335 292 Slightly volatile Days Of Sales Outstanding 65.31 110 81.9603 Slightly volatile Free Cash Flow Operating Cash Flow Ratio 0.42 0.5758 0.7157 Pretty Stable Cash Flow Coverage Ratios 1.12 1.1769 38.6993 Slightly volatile Price To Book Ratio 20.34 19.3756 16.8858 Slightly volatile Fixed Asset Turnover 1.7 1.7872 2.862 Slightly volatile Capital Expenditure Coverage Ratio 2.71 2.3576 4.7262 Slightly volatile Price Cash Flow Ratio 24.13 22.9823 20.9734 Slightly volatile Enterprise Value Multiple 21.92 20.8716 18.0273 Slightly volatile Debt Ratio 0.23 0.2207 0.0665 Slightly volatile Cash Flow To Debt Ratio 1.12 1.1769 38.6993 Slightly volatile Price Sales Ratio 10.05 9.5733 8.073 Slightly volatile Return On Assets 0.14 0.2168 0.2853 Pretty Stable Asset Turnover 0.66 0.6235 0.9293 Slightly volatile Net Profit Margin 0.37 0.3478 0.3131 Slightly volatile Gross Profit Margin 0.58 0.8467 0.8001 Pretty Stable Price Fair Value 20.34 19.3756 16.8858 Slightly volatile Return On Equity 0.74 0.7038 0.6474 Slightly volatile
Novo Nordisk Valuation Data		Trends
Current Value Last Year Historical Average  10 Year Trend Market Cap 781.9 B 744.7 B 701.7 B Slightly volatile Enterprise Value 765.7 B 729.2 B 687.1 B Slightly volatile

Novo Fundamental Market Drivers

Novo Upcoming Events

About Novo Nordisk Financial Statements

Pair Trading with Novo Nordisk

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Novo Nordisk position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novo Nordisk will appreciate offsetting losses from the drop in the long position's value.When determining whether Novo Nordisk AS offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Novo Nordisk's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Novo Nordisk As Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Novo Nordisk As Stock:

How To Invest In Novo Details

Is Novo Stock a good investment? Details

What is Novo Nordisk's Net Worth? Details

Largest Pharmaceuticals Companies View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies View

Altman Z Score Details

Piotroski F Score Details

Beneish M Score Details

Financial Analysis Details

Buy or Sell Advice Details

Earnings Projections Details